Solar Pharma slips 3% on manufacturing halt at Mohali unit for corrective actions 3 min read Politics Solar Pharma slips 3% on manufacturing halt at Mohali unit for corrective actions jasabacklink 7 months ago JP Morgan sees a restricted 1-2 % impression on Solar Pharma’s FY24 earnings as a result of manufacturing halt. Shares Solar Pharmaceutical Industries misplaced 3 %... Read More
Solar Pharma slips 3% on manufacturing halt at Mohali unit for corrective actions 
The Artwork of Buying and selling: Navigating the Inventory Market with Confidence 
Piers Morgan calls trans athletes participation in girls’s sports activities ‘grotesquely unfair,’ requires boycotts 
PagerDuty Inventory: Current Weak point Gives Higher Shopping for Alternatives (NYSE:PD) 
Yum Manufacturers: Undervalued, And Poised For Lengthy-Time period Progress (NYSE:YUM)